Global Next Generation Sequencing (NGS) Service Market Growth (Status and Outlook) 2023-2029

Global Next Generation Sequencing (NGS) Service Market Growth (Status and Outlook) 2023-2029

The global Next Generation Sequencing (NGS) Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Next Generation Sequencing (NGS) Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Next Generation Sequencing (NGS) Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Next Generation Sequencing (NGS) Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Next Generation Sequencing (NGS) Service players cover 454 Life Sciences Corporation (Roche), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina and Life Technology Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Next Generation Sequencing (NGS) Service Industry Forecast” looks at past sales and reviews total world Next Generation Sequencing (NGS) Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Next Generation Sequencing (NGS) Service sales for 2023 through 2029. With Next Generation Sequencing (NGS) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Sequencing (NGS) Service industry.

This Insight Report provides a comprehensive analysis of the global Next Generation Sequencing (NGS) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next Generation Sequencing (NGS) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next Generation Sequencing (NGS) Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Sequencing (NGS) Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Sequencing (NGS) Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Sequencing (NGS) Service market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing

Segmentation by application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
454 Life Sciences Corporation (Roche)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar

Please note: The report will take approximately 2 business days to prepare and deliver.